Chemlal, D., Pochard, C., Jacquier, V., Bruyer, A., Gabellier, L., Fornero, L., . . . Herbaux, C. (2025). CD200 immune checkpoint expression is associated with inferior outcome in multiple myeloma patients treated with anti-CD38 monoclonal antibodies. Taylor & Francis Group.
Chicago Style (17th ed.) CitationChemlal, Djamila, et al. CD200 Immune Checkpoint Expression Is Associated with Inferior Outcome in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal Antibodies. Taylor & Francis Group, 2025.
MLA (9th ed.) CitationChemlal, Djamila, et al. CD200 Immune Checkpoint Expression Is Associated with Inferior Outcome in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal Antibodies. Taylor & Francis Group, 2025.
Warning: These citations may not always be 100% accurate.